Please tell us what you thought about today’s presentation by taking the survey below:
As a follow-up to the previous webinar, “An Introduction to the AASCTM,” this webinar will re-ground on the current landscape of Alzheimer’s dementia (AD) and the negative impact agitation in Alzheimer’s dementia (AAD) has on both caregivers and patients. Additionally, it will introduce guidance on how caregivers should use the AASCTM to support patients. During this session, presenters will provide a didactic overview and engage in role-playing scenarios to illustrate how community caregivers can use the AASCTM to facilitate a conversation with their health care provider (HCP).
Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine
CEO & Founder of Embodied Labs
Medical Science Liaison
Speakers Dr. Marc E. Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Katie Sulkowski, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Notifications
